Home › Psychotic Disorders › Illinois
Psychotic Disorders clinical trials in Illinois
5 studies for Psychotic Disorders are looking for participants at sites in Illinois.
Cities in Illinois
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
- Neurocrine Clinical Site, Naperville
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT07105111A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
- Clinical Site, Chicago
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Sep 1, 2026 · NCT07459647Transition Care for FEP
- University of Chicago Ingalls Memorial Hospital, Harvey
RecruitingObservational study
Ages 18 to 40 · All sexes · Updated Jul 20, 2026 · NCT07713849CLOZAPINE Response in Biotype-1
- University of Chicago, Chicago
RecruitingPhase 4
Ages 18 to 60 · All sexes · Updated May 11, 2026 · NCT04580134Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services
- University of Chicago Medical Center, Chicago
RecruitingObservational study
Ages 18 to 40 · All sexes · Updated Mar 10, 2026 · NCT06740383From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.